Singapore dừng sử dụng 2 loại vắcxin phòng cúm của Hàn Quốc, Pháp

Các cơ quan y tế Singapore gồm Bộ Y tế (MOH) và Cơ quan Khoa học Y tế (HSA) đã khuyến cáo tạm dừng sử dụng hai loại vắcxin phòng cúm SKYCellflu Quadrivalent và Vaxigrip Tetra sau khi Hàn Quốc ghi nhận một số ca tử vong sau khi tiêm phòng.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh